Clinical Trial Site

Dubai +971

1 studies enrolling now · 4 studies all time

What they study most

End Stage Renal Disease, Primary Hyperoxaluria, Primary Hyperoxaluria Type 1, Primary Hyperoxaluria Type 1 (PH1), Primary Hyperoxaluria Type 2, Primary Hyperoxaluria Type 3

Studies at this site

• Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD — Recruiting now
• Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function — Completed
• A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1 — Completed
• A Study to Evaluate Lumasiran in Children and Adults With Primary Hyperoxaluria Type 1 — Completed